Safety and Efficacy Extension Study of GreenGeneâ„¢ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT02027779
- Locations
- 🇺🇸
Long Island Jewish Medical Center - Hemophilia Treatment Center, New Hyde Park, New York, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
- First Posted Date
- 2013-11-19
- Last Posted Date
- 2015-07-03
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 420
- Registration Number
- NCT01987011
- Locations
- 🇰🇷
Inha University Hospital, Inchon, Korea, Republic of
🇰🇷Korea University Ansan Hospital, Ansan, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2013-10-01
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 46
- Registration Number
- NCT01954238
- Locations
- 🇺🇸
PAREXEL Internatonal, Early phase clinical unit _Los Angeles, California, United States
Safety Study of MG1102 in Patients With Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2013-03-13
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT01809912
- Locations
- 🇰🇷
Yonsei Cancer Center, Yonsei University Severance Hospital, Seoul, Korea, Republic of
To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2016-01-15
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT01750814
Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2014-02-28
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 198
- Registration Number
- NCT01696305
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
🇰🇷Konkuk University Medical Center, Seoul, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Korea, Republic of
Evaluate the Safety and Exploratory Efficacy of GC1119
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 8
- Registration Number
- NCT01653444
- Locations
- 🇰🇷
Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of
🇰🇷Soon Cung Hyang University Hospital, Yongsan-gu, Seoul, Korea, Republic of
🇰🇷Ajou University School of Medicine, Yeongtong-gu, Suwon, Korea, Republic of
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT01651234
- Locations
- 🇺🇸
Quintiles Phase1 Unit, Overland Park, Kansas, United States
Safety and Efficacy of Hunterase
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT01645189
- Locations
- 🇰🇷
Samsug Medical Center, Seoul, Korea, Republic of
A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT01624532
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of